Given the heterogeneous clinical profiles for NTM pulmonary disease, what radiographic or other criteria determine which patients with culture positivity for MAC lung disease should be treated and which are suitable for “watch, wait, and monitor?”

Given the heterogeneous clinical profiles for NTM pulmonary disease, what radiographic or other criteria determine which patients with culture positivity for MAC lung disease should be treated and which are suitable for “watch, wait, and monitor?”

CLICK HERE FOR CME CREDIT

Given the heterogeneous clinical profiles for NTM pulmonary disease, what radiographic or other criteria determine which patients with culture positivity for MAC lung disease should be treated and which are suitable for “watch, wait, and monitor?” 

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Julie Philley, MD

Julie Philley, MD

Chair of the Department of Medicine
Chief of Pulmonary and Critical Care
UT Health North Campus Tyler
The University of Texas Health Sciences Center
Houston, Texas